Drugs / DW-330SR2
last change Nov 2014 re-read 2 minutes ago

DW-330SR2

Developed for
chronic pain syndrome
Investigated by
Daewon Pharmaceutical Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02375633 Apr → Nov 2014 chronic pain syndrome Daewon Pharmaceutical Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DW-330SR2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02375633